Genmab

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

1 month ago   |   Xconomy

The first treatment for a rare disease that causes eye bulging and double vision received an FDA nod on Tuesday, weeks ahead of the agency's March 8 deadline to review the...
Read more ...

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

1 month ago   |   Xconomy

Neon Therapeutics closed 2019 by curtailing its cancer vaccine programs and laying off 24 percent of its workforce, part of a corporate restructuring aimed at finding a new...
Read more ...

Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More

Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More

3 monthes ago   |   Xconomy   |   2 articles

The brain has stymied many efforts to develop new neuroscience drugs, leading a number of big pharmaceutical companies to pull back on such R&D work. This week, Amgen joined...
Read more ...

BioNTech files for IPO after investor reneges on $88M promise 

5 monthes ago   |   Fierce Biotech

BioNTech has filed to raise $100 million n a Nasdaq IPO. The proposal would set BioNTech up to run clinical trials of three mRNA assets while funding its share of...
Read more ...

Celgene Adds Cell Therapies From Immatics With Bristol Sale In Sight

Celgene Adds Cell Therapies From Immatics With Bristol Sale In Sight

5 monthes ago   |   Xconomy   |   2 articles

Even as its sale to Bristol-Myers Squibb inches closer to completion , Celgene-long known for its web of biotech partnerships -has inked another alliance. Celgene will...
Read more ...

Bio Roundup: Opioid Exposé, Gilead's Gambit, Life Science IPOs & More

Bio Roundup: Opioid Exposé, Gilead's Gambit, Life Science IPOs & More

7 monthes ago   |   Xconomy

The opioid crisis reaches all corners of the nation, and newly released data this week revealed how the growth of the epidemic tracked with a massive increase in the production...
Read more ...

Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts

Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts

7 monthes ago   |   Xconomy

Initial public offerings took a brief summer break the week of Independence Day, but healthcare IPO activity resumed this week as three more companies joined the US public...
Read more ...

Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More

Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More

8 monthes ago   |   Xconomy

Is one of the bigger biopharma acquisitions of the year in trouble? This past week, antitrust regulators once again delayed Roche's planned $4.8 billion buyout of gene therapy...
Read more ...

J&J bags $150M option on Genmab's Darzalex successor 

8 monthes ago   |   Fierce Biotech

Genmab and Johnson & Johnson have teamed up to develop a successor to their multiple myeloma blockbuster Darzalex. The deal gives J&J the option to license the asset after...
Read more ...

Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More

Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More

8 monthes ago   |   Xconomy

Pharmaceutical companies that make or market opioids have found themselves in legal hot water, and much of the heat is coming from Oklahoma. This week, a trial began litigating...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...